934OAlienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. (23rd October 2018) - Ray-Coquard, I L; Harter, P; Lorusso, D; Dalban, C; Vergote, I B; Fujiwara, K; Gladieff, L; Lueck, H-J; Floquet, A; Lesoin, A F; Schnelzer, A; Pignata, S; et al.